Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

WuXi

China flag thumb

China turns down one of two Sovaldi patents

Advocacy group attempting to block drug in other emerging markets too

- PMLiVE

China to relax pricing curbs from June

Reports suggest medicine sales could reach $185bn in the region by 2018

Webinar: Understanding the patient journey in China

The Chinese healthcare market is experiencing a period of great change. Utilising local knowledge and detailed case studies, this webinar examines the likely impact on the patient journey and considers...

Research Partnership

Ageing in China: The Implications for Healthcare

Published in eye for pharma 12 December by Marc Yates

Research Partnership

Eli Lilly HQ

Lilly signs cancer pact with Chinese biotech

Marks first major deal between a Western pharma company and a Chinese biotech

- PMLiVE

GSK fires Chinese staff over corruption charges

110 employees reportedly dismissed for misconduct

- PMLiVE

ICON to open global innovation hub in Ireland

Will create 200 new jobs

- PMLiVE

GSK set ‘to cut 1,000 jobs’ in China

Pharma company's troubles in the country reportedly continue

China flag thumb

China approves home-grown polio vaccine

Country clamps down on recent outbreaks of disease

- PMLiVE

Type 2 diabetes market in Asia-Pacific to hit $10.5bn by 2020

Analysts predict increase of $4bn from 2013 figure

Bristol-Myers Squibb (BMS) building

BMS to fund hepatitis projects in China and India

Pharma firm awards nine grants to support care for high-risk patients

- PMLiVE

MRC Technology and Yabao form Parkinson’s partnership in China

Companies will target specific kinase involved in neurodegeneration

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links